Dirk Hose
Impact in
- Hematology top 0.1%
- Multiple Myeloma Research and Treatments
- Oncology top 1%
- Peptidase Inhibition and Analysis
Papers in
- Hematology 145
- Multiple Myeloma Research and Treatments 142
-
- Protein Degradation and Inhibitors 37
- Glycosylation and Glycoproteins Research 20
- Amyloidosis: Diagnosis, Treatment, Outcomes 19
- Ubiquitin and proteasome pathways 15
- Co-authors
- Hartmut Goldschmidt (131 shared papers)Bernard Klein (84 shared papers)Jérôme Moreaux (69 shared papers)Thierry Rème (52 shared papers)Anja Seckinger (91 shared papers)John De Vos (30 shared papers)Anna Jauch (52 shared papers)Alboukadel Kassambara (20 shared papers)
- Journals
- Blood (62 papers)Haematologica (13 papers)Oncotarget (9 papers)Leukemia (6 papers)Experimental Hematology (5 papers)
- Partner nations
- GermanyFranceUnited States
In The Last Decade
Dirk Hose
203 papers receiving 6.9k citations
Peers
Comparison fields: 5 of 119
- Hematology 3.2k
- Oncology 1.8k
- Genetics 631
- Molecular Biology 3.9k
- Immunology 1.1k
Countries citing papers authored by Dirk Hose
This map shows the geographic impact of Dirk Hose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Hose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Hose more than expected).
Fields of papers citing papers by Dirk Hose
This network shows the impact of papers produced by Dirk Hose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Hose. The network helps show where Dirk Hose may publish in the future.
Co-authors
The 25 scholars most cited alongside Dirk Hose, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 211 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 225 | |
| 2 | 2009 | 208 | |
| 3 | 2009 | 199 | |
| 4 | 2005 | 197 | |
| 5 | 2006 | 192 | |
| 6 | 2015 | 155 | |
| 7 | 2013 | 154 | |
| 8 | 2010 | 151 | |
| 9 | 2009 | 128 | |
| 10 | 2004 | 127 | |
| 11 | 2010 | 124 | |
| 12 | 2007 | 116 | |
| 13 | 2014 | 115 | |
| 14 | 2010 | 114 | |
| 15 | 2011 | 113 | |
| 16 | 2015 | 107 | |
| 17 | 2009 | 105 | |
| 18 | 2012 | 103 | |
| 19 | 2007 | 96 | |
| 20 | 2012 | 89 |
About Dirk Hose
Dirk Hose is a scholar working on Hematology, Molecular Biology, Oncology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 211 papers that have together received 7.0k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (142 papers), Protein Degradation and Inhibitors (37 papers), Glycosylation and Glycoproteins Research (20 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (19 papers), Ubiquitin and proteasome pathways (15 papers), Immunotherapy and Immune Responses (15 papers), Peptidase Inhibition and Analysis (15 papers) and Monoclonal and Polyclonal Antibodies Research (14 papers). The work is most often cited by research in Hematology (3.2k citations), Oncology (1.8k citations), Genetics (631 citations), Molecular Biology (3.9k citations) and Immunology (1.1k citations). Dirk Hose has collaborated with scholars based in Germany, France and United States. Frequent co-authors include Hartmut Goldschmidt, Bernard Klein, Jérôme Moreaux, Thierry Rème, Anja Seckinger, John De Vos, Anna Jauch, Alboukadel Kassambara, Anthony D. Ho and Jens Hillengaß. Their work appears in journals such as Blood, Haematologica, Oncotarget, Leukemia and Experimental Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.